These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4895749)

  • 1. [Therapeutic value of cryoprecipitate in hemophilia A].
    Lopaciuk S; Szczepański M; Klenowska Z; Daszyński J; Pawelski S
    Pol Tyg Lek; 1969 Jun; 24(22):829-32. PubMed ID: 4895749
    [No Abstract]   [Full Text] [Related]  

  • 2. A hemophilia home care program utilizing cryoprecipitate.
    Shanberge JN; Kratz NL; Aster RH
    Scand J Haematol Suppl; 1977; 30():85-6. PubMed ID: 267309
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylactic therapy in classical hemophilia: a preliminary report.
    Robinson PM; Tittley P; Smiley RK
    Can Med Assoc J; 1967 Sep; 97(11):559-61. PubMed ID: 6050888
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS in a patient with hemophilia receiving mainly cryoprecipitate.
    Gerstein HC; Fanning MM; Read SE; Shepherd FA; Glynn MF
    Can Med Assoc J; 1984 Jul; 131(1):45-7. PubMed ID: 6428732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of the preparation and use of antihemophilic fractions in France. (Their use in surgery in hemophilia)].
    Ménaché D; Josso F; Steinbuch M; Soulier JP
    Transfusion (Paris); 1966; 9(3):237-44. PubMed ID: 5969559
    [No Abstract]   [Full Text] [Related]  

  • 6. Design of clinical studies with recombinant factor VIII. The rFactor VIII Clinical Trial Group.
    Pennington JE; Schwartz RS
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):27-8. PubMed ID: 1908123
    [No Abstract]   [Full Text] [Related]  

  • 7. [Substitution therapy of hemophilia A].
    Vlcková M
    Vnitr Lek; 1979 Mar; 25(3):295-300. PubMed ID: 433175
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemophilia home transfusion program: effect of cryoprecipitate utilization.
    Lazerson J
    J Pediatr; 1973 May; 82(5):857-9. PubMed ID: 4698962
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihemophilic activity of donor blood].
    Shuruev AS
    Probl Gematol Pereliv Krovi; 1976; 21(9):45-6. PubMed ID: 1005391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE; Kerkhofs H; Leeksma CH
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemofil and other factor VIII concentrates.
    Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of haemophilia with purified factor 8 (FI-O-Ta).
    de Tezanos Pinto M
    Hemostase; 1966; 6(1):65-71. PubMed ID: 5911788
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term treatment of hemophilia A with plasma fractions].
    Mey U; Gaerisch F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):357-62. PubMed ID: 4195282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hemophilia].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of haemophilia.
    Br Med J; 1967 Apr; 2(5544):65-6. PubMed ID: 6020849
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
    Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
    Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of the hemophilias.
    Levin J
    Md State Med J; 1968 Sep; 17(9):75-7. PubMed ID: 5681701
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients.
    Prentice CR
    Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and clinical evaluation of a factor 8 concentrate.
    Johnson AJ; Karpatkin MH; Newman J
    Bibl Haematol; 1970; 34():30-9. PubMed ID: 5436351
    [No Abstract]   [Full Text] [Related]  

  • 20. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.